Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
Volume 11, Issue 4, Pages 1089-1099Publisher
ELSEVIER
DOI: 10.1016/j.jaip.2022.10.027
Keywords
Bronchiectasis; Eosinophil; Phenotype; Asthma; Allergic bronchopulmonary aspergillosis; Overlap syndrome; Biologics
Categories
Ask authors/readers for more resources
Bronchiectasis is a complex and heterogeneous disease with various causes. It is characterized by neutrophilic inflammation but can also involve eosinophilic inflammation. Eosinophilic diseases, such as asthma and allergic bronchopulmonary aspergillosis, may coexist with bronchiectasis. Additionally, some bronchiectasis patients exhibit eosinophilia without identified concomitant diseases, and the role of eosinophils in this condition is not fully understood.
Bronchiectasis is a complex and heterogeneous disease with a myriad of pulmonary and extrapulmonary etiologies. Bronchiectasis has a predominantly neutrophilic inflammatory profile. However, eosinophilic inflammation has also been documented in both the airways and the systemic circulation. Various diseases (eg, asthma, allergic bronchopulmonary aspergillosis, chronic rhinosinusitis with nasal polyps) characterized by heightened type 2 airway inflammatory responses, including blood or sputum eosinophilia, may coexist with bronchiectasis. Apart from those eosinophilic etiologies or comorbidities related to bronchiectasis, around 20% of patients with bronchiectasis have peripheral eosinophilia (at least 3% or 300 eosinophils/mL) with no identified concomitant disease (also termed eosinophilic bronchiectasis), whose roles have not been fully understood. The two key points regarding these observations are that eosinophils confer both bactericidal and antiviral properties against common pathogenic microorganisms that are usually detected in bronchiectasis, and that eosinophilic bronchiectasis has been associated with better therapeutic response to inhaled corticosteroids and other anti-TH2 profile treatments. In this review, we summarize the most significant evidence regarding the role of eosinophils in patients with bronchiectasis, including the association of bronchiectasis with eosinophilic diseases (as etiologies or comorbidities), and existing data on eosinophilic bronchiectasis not related to eosinophilic disorders.(c) 2022 American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:1089-99)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available